Using higher PEEP with mask noninvasive ventilation for people with pneumonia or ARDS
Official title: Effect of High Versus Low Positive End-Expiratory Pressure on Intubation-Free Survival in Patients With Pneumonia or ARDS Receiving Noninvasive Ventilation: A Multicenter Randomized Controlled Trial
Run by Chongqing Medical University · NCT07298889 · Data updated 2026-11-12
This trial will test whether giving higher PEEP through a mask during noninvasive ventilation helps adults with pneumonia or ARDS avoid intubation and improve oxygenation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 706 (estimated) |
| Sponsor | Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing) |
| Status | Recruiting |
| Started | January 4, 2026 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT07298889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with PaO2/FiO2 ≤300 mmHg or SpO2/FiO2 ≤315, expected to need NIV for more than 12 hours, and with preserved consciousness (GCS ≥13) are the intended participants.
✕Probably not a fit
Patients with acute-on-chronic respiratory failure, congestive heart failure, pneumothorax, recent thoracic/esophageal surgery, NIV after recent extubation, pregnancy, or those needing emergency intubation are excluded and unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares different levels of positive end-expiratory pressure (PEEP) delivered via mask during noninvasive ventilation for adults with pneumonia or ARDS. Participants meeting oxygenation and consciousness criteria and expected to need NIV for more than 12 hours will receive NIV with specified PEEP settings. The study will track outcomes such as NIV failure, need for intubation, oxygenation measures, and clinical course in the ICU or hospital. The aim is to determine whether higher PEEP improves respiratory status and reduces the rate of progression to invasive mechanical ventilation.
Why it matters
Potential benefit: If successful, higher mask-delivered PEEP could lower the rate of noninvasive ventilation failure and reduce the need for intubation in these patients.
How similar studies have gone: High PEEP has improved oxygenation in invasively ventilated patients with lung consolidation, but evidence for applying high PEEP during mask noninvasive ventilation is limited and not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years * PaO2/FiO2 ≤300 mmHg or SpO2/FiO2 ≤315(SpO2 ≤97%) * Anticipated NIV duration \> 12 h * Preserved consciousness (GCS≥13) Exclusion Criteria: * Use of NIV \> 24 h before randomization * Acute-on-chronic respiratory failure * Congestive heart failure * Use of NIV after extubation (within 48 hours) * Contraindications to NIV (e.g., anatomical malformations, recent pulmonary/esophageal surgery \[within 7 days\]) * Pneumothorax * NIV intolerance * Refusal to participate * Pregnancy * Need for emergency intubation
Where it's running
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China Recruiting
Study contacts
- Study coordinator: Mengyi Ma
- Email: 1062914316@qq.com
- Phone: 86-023-89012680
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring blood flow and response to fluids in patients on ECMO
This study is testing different ways to monitor blood flow and heart function in adults receiving VA ECMO treatment to see which methods work best for their care.
-
Testing monitoring methods for patients on ECMO support
This study is testing different ways to monitor heart function and fluid levels in patients on ECMO support for severe breathing problems to see which methods work best.
-
Understanding risk factors and biomarkers in ARDS, sepsis, and pneumonia
This study is trying to find out what causes acute respiratory distress syndrome, sepsis, and pneumonia by collecting health information and samples from hospitalized adults to help improve treatment for these conditions.
-
Using Xanthohumol to help treat septic shock
This study is testing if a natural compound called Xanthohumol can help improve recovery for patients with septic shock who need breathing support.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.